Veru Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for cardiometabolic and inflammatory diseases. Its pipeline includes enobosarm, an oral selective androgen receptor modulator (SARM) being developed to enhance GLP-1 RA weight loss by preserving lean mass and reducing fat, and sabizabulin, a microtubule disruptor for atherosclerotic cardiovascular disease inflammation. On December 30, 2024, Veru sold its FDA-approved FC2 Female Condom commercial product.
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-17 | 2025-09-30 | 0001437749-25-038089 | EDGAR | 73K words |
| 2024-12-16 | 2024-09-30 | 0001437749-24-037576 | EDGAR | — |
| 2023-12-08 | 2023-09-30 | 0000863894-23-000017 | EDGAR | — |
| 2022-12-05 | 2022-09-30 | 0000863894-22-000017 | EDGAR | — |
| 2021-12-02 | 2021-09-30 | 0000863894-21-000013 | EDGAR | — |
| 2020-12-10 | 2020-09-30 | 0000863894-20-000021 | EDGAR | — |
| 2019-12-12 | 2019-09-30 | 0000863894-19-000014 | EDGAR | — |
| 2018-12-13 | 2018-09-30 | 0000863894-18-000011 | EDGAR | — |
| 2018-01-02 | 2017-09-30 | 0001562762-17-000231 | EDGAR | — |
| 2016-12-12 | 2016-09-30 | 0000863894-16-000032 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001437749-26-026664 | EDGAR | — |
| 2026-02-11 | 2025-12-31 | 0001437749-26-003725 | EDGAR | 26K words |
| 2025-08-12 | 2025-06-30 | 0001437749-25-026072 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001437749-25-015330 | EDGAR | — |
| 2025-02-13 | 2024-12-31 | 0001437749-25-003734 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001437749-24-025338 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000863894-24-000011 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0000863894-24-000008 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000863894-23-000009 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000863894-23-000006 | EDGAR | — |
| 2023-02-09 | 2022-12-31 | 0000863894-23-000003 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000863894-22-000013 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-10 | 0001193125-26-341187 | EDGAR | — |
| 2026-03-13 | 0001437749-26-008216 | EDGAR | 14K words |
| 2026-02-11 | 0001193125-26-045527 | EDGAR | — |
| 2025-12-17 | 0001193125-25-321663 | EDGAR | — |
| 2025-10-30 | 0001193125-25-258565 | EDGAR | — |
| 2025-09-26 | 0001437749-25-029912 | EDGAR | — |
| 2025-08-27 | 0001437749-25-027858 | EDGAR | — |
| 2025-08-12 | 0001437749-25-026037 | EDGAR | — |
| 2025-08-12 | 0001193125-25-178463 | EDGAR | — |
| 2025-07-25 | 0001437749-25-023521 | EDGAR | — |
318 total filings indexed. 286 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000863894 |
| Ticker | VERU |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | WI |
| Website | https://www.verupharma.com |
| Listed | 1990-06-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VERU (~200 tokens, structured JSON with cryptographic provenance)